We are live on ! Find out more
HCM

Harvey Capital Management Portfolio holdings

AUM $439M
1-Year Est. Return 37.68%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+37.68%
3 Year Est. Return
+140.63%
5 Year Est. Return
+188.51%
10 Year Est. Return
+681.53%
AUM
$272M
AUM Growth
+$11.2M
Cap. Flow
-$4.29M
Cap. Flow %
-1.58%
Top 10 Hldgs %
46.81%
Holding
84
New
13
Increased
17
Reduced
27
Closed
3

Top Buys

Rank Stock Value
1
CEMP
Cempra, Inc.
CEMP
+$6.47M
2
BABA icon
Alibaba
BABA
+$5.03M
3
MNDT
Mandiant, Inc. Common Stock
MNDT
+$4.18M
4
PRU icon
Prudential Financial
PRU
+$3.74M
5
PFPT
Proofpoint, Inc.
PFPT
+$3.29M

Top Sells

Rank Stock Value
1
NPSP
NPS PHARMACEUTICALS INC
NPSP
+$15.4M
2
PCYC
PHARMACYCLICS INC
PCYC
+$7.12M
3
MHR
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
+$4.36M
4
QCOM icon
Qualcomm
QCOM
+$3.35M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$2.56M

Sector Composition

Rank Sector Weight
1 Healthcare 26.25%
2 Technology 19.76%
3 Communication Services 16.32%
4 Industrials 7.91%
5 Energy 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$22.2M 8.15%
712,976
-5,140
-0.7% -$155K
CELG
2
DELISTED
Celgene Corp
CELG
$16.9M 6.23%
147,000
-3,100
-2% -$370K
ACAD icon
3
Acadia Pharmaceuticals
ACAD
$4.25B
$16.4M 6.03%
503,300
-74,400
-13% -$2.56M
GILD icon
4
Gilead Sciences
GILD
$161B
$13.1M 4.83%
133,900
-16,975
-11% -$1.72M
TTPH
5
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$11.6M 4.28%
15,895
+607
+4% +$456K
PARA
6
DELISTED
Paramount Global Class B
PARA
$10.7M 3.92%
176,000
-1,800
-1% -$105K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$10.4M 3.82%
378,837
+2,306
+0.6% +$61.8K
EMC
8
DELISTED
EMC CORPORATION
EMC
$9.4M 3.46%
367,950
+67,200
+22% +$1.85M
MNDT
9
DELISTED
Mandiant, Inc. Common Stock
MNDT
$8.33M 3.06%
212,200
+108,100
+104% +$4.18M
TWX
10
DELISTED
Time Warner Inc
TWX
$8.24M 3.03%
97,616
-900
-0.9% -$74.8K
GE icon
11
GE Aerospace
GE
$367B
$7.49M 2.75%
62,988
-1,356
-2% -$161K
CEMP
12
DELISTED
Cempra, Inc.
CEMP
$7.38M 2.71%
+215,150
New +$6.47M
BKNG icon
13
Booking.com
BKNG
$138B
$6.47M 2.38%
138,875
-7,925
-5% -$355K
T icon
14
AT&T
T
$165B
$6.09M 2.24%
246,896
-3,972
-2% -$101K
OUT icon
15
Outfront Media
OUT
$5.64B
$5.71M 2.1%
193,944
+418
+0.2% +$11.9K
PTLA
16
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.68M 2.09%
149,680
+13,050
+10% +$448K
CXO
17
DELISTED
CONCHO RESOURCES INC.
CXO
$5.4M 1.98%
46,570
-650
-1% -$70.8K
ORCL icon
18
Oracle
ORCL
$331B
$5.37M 1.97%
124,350
-1,700
-1% -$73.7K
NVAX icon
19
Novavax
NVAX
$1.23B
$5.1M 1.88%
30,848
+1,115
+4% +$181K
BABA icon
20
Alibaba
BABA
$269B
$4.64M 1.7%
+55,725
New +$5.03M
AERI
21
DELISTED
Aerie Pharmaceuticals
AERI
$4.62M 1.7%
147,400
+12,000
+9% +$348K
PCYC
22
DELISTED
PHARMACYCLICS INC
PCYC
$4.58M 1.68%
17,900
-36,870
-67% -$7.12M
CTRA
23
DELISTED
Coterra Energy
CTRA
$4.49M 1.65%
152,000
-500
-0.3% -$14.2K
QCOM icon
24
Qualcomm
QCOM
$176B
$4.33M 1.59%
62,470
-47,550
-43% -$3.35M
CBI
25
DELISTED
Chicago Bridge & Iron Nv
CBI
$4.08M 1.5%
82,751
-700
-0.8% -$29.4K
1
2 3 4

Similar funds

STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
CDMG
Creek Drive Management Group San Francisco, California $439M AUM
WAS
Winch Advisory Services Appleton, Wisconsin $438M AUM 17.59% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DA
Detalus Advisors St. Louis, Missouri $438M AUM 17.09% 1-Year Est. Return
CCT
Capital City Trust Tallahassee, Florida $437M AUM 23.86% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return

Harvey Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Harvey Capital Management held 84 positions worth $272M, up 4.3% from $261M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Harvey Capital Management's Q1 2015 filing shows 13 new, 17 increased, 27 reduced and 3 closed positions. Its largest new stake was Cempra, Inc.: 215,150 shares worth $7.38M. The largest sale was NPS PHARMACEUTICALS INC, an estimated $15.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Communication Services.

  • Harvey Capital Management's largest Q1 2015 buy was Cempra, Inc.: 215,150 shares worth $7.38M.
  • Harvey Capital Management added most to Mandiant, Inc. Common Stock in Q1 2015, an estimated $4.18M increase.
  • Harvey Capital Management's biggest Q1 2015 reduction was PHARMACYCLICS INC, cutting an estimated $7.12M.
  • Harvey Capital Management fully exited NPS PHARMACEUTICALS INC in Q1 2015, selling an estimated $15.4M.
  • Harvey Capital Management's ten largest holdings make up 47% of its $272M portfolio in Q1 2015.
  • Harvey Capital Management opened 13 new positions and closed 3 in Q1 2015.
  • Harvey Capital Management's portfolio value rose 4.3% quarter-over-quarter to $272M.

Based on Harvey Capital Management's 13F filing for Q1 2015, filed 5 May 2015.